Top Markets
Coin of the day
Imunon, Inc. Imunon, Inc.

Imunon, Inc.

CLSN
Pozycja w akcjach #35102
Imunon, Inc. is a biotechnology firm in the clinical development stage,... Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon, Inc. maintains its operational base in Lawrenceville, New Jersey.
Cena akcji
$1.96
Ostatnia synchronizacja: 2022-09-20
Kapitalizacja rynkowa
$4.46M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Imunon, Inc. (CLSN)

Kategoria

Historia ceny akcji dla Imunon, Inc. (CLSN)
Najwyższa cena zamknięcia: $2.07 dnia 2022-09-01

Najniższa cena zamknięcia: $3.32K dnia 2008-06-01
Historia cen akcji firmy Imunon, Inc. od 2008 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2022 -76.70%
2021 -7.06%
2020 -56.43%
2019 -9.75%
2018 -34.36%
2017 -62.92%
2016 -73.54%
2015 -19.45%
2014 -37.80%
2013 -89.21%
2012 314.30%
2011 -19.63%
2010 -19.31%
2009 14.94%
2008 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE